NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Telehealth & HPV Self-Collection
Telehealth & HPV Self-Collection

NCT05089825

CompletedNA

Sponsor: OHSU Knight Cancer Institute

Conditions: Gynecologic Cancer

Interventions: Receive routine instructions, Telehealth-based instructional visit and receive routine instructions

Countries: United States

This study aims to compare the efficacy and participant experience of telehealth-based, self-collected cervical cancer screening to mail-based, self-collected cervical cancer screening across the adult female screening lifespan. This will be done by evaluating sufficient Human papillomavirus (HPV) sample collection and determining preference for self-collection verses provider collection, comparing role of telehealth in pre- and post- menopausal women's comfort with self-collection, comparing self-collection completion rates for women with and without telehealth visits.

Eligibility overview

Sex: FEMALE

Age: 25 Years to 85 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Individuals with a cervix who are eligible for primary HPV testing (age 25 and older) according to national cervical cancer screening guidelines.
* Pregnant women are eligible for participation in this study as the collection process poses no threat to the woman or her fetus.

Exclusion Criteria:

* Individuals without a cervix
* Have had prior pelvic radiation therapy or brachytherapy
* Active or former diagnosis of ovarian, uterine, or cervical cancer unless determined eligible by PI upon further review of history and treatment
* Individuals less than age 25 or no longer eligible/recommended to undergo cervical cancer screening
* Adults who are unable to consent or are decisionally impaired
* Individuals who are not English speaking
Locations (1)
  • Portland, Oregon, United States